Market & Alt Data
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-19 | 2026-10-20 | Bhanji Muna | Director | Sale | 1,864 | $43.70 | $81K | 40.9K | View | |
| 2026-09-21 | 2026-09-22 | Leite John | Global Chief Commercial Off | Sale | 4,015 | $40.00 | $161K | 124.3K | View | |
| 2026-09-14 | 2026-09-16 | Holstein Jens | Director | Sale | 5,000 | $40.95 | $205K | 27.5K | View | |
| 2026-09-04 | 2026-09-04 | Febbo Phillip G. | Chief Scientific & Med Officer | Sale | 13.1K | $43.05 | $564K | 133.0K | View | |
| 2026-09-04 | 2026-09-04 | Chambers Rebecca | Chief Financial Officer | Sale | 3,652 | $43.10 | $157K | 166.0K | View |
Informational purposes only, not investment advice.
tormere.com/research/VCYT · generated 2026-10-28
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-10-19 | Bhanji Muna | S | 1,864 | $81,456.8 |
| 2026-09-21 | Leite John | S | 4,015 | $160,600 |
| 2026-09-14 | Holstein Jens | S | 5,000 | $204,747 |
| 2026-09-04 | Febbo Phillip G. | S | 10,405 | $446,304.79 |
| 2026-09-04 | Chambers Rebecca | S | 1,175 | $51,363.95 |
Tormere — informational purposes only, not investment advice.